554 related articles for article (PubMed ID: 15963709)
1. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
Salgame P
Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. [Protective immunity against Mycobacterium tuberculosis].
Kawamura I
Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
[TBL] [Abstract][Full Text] [Related]
4. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
Reiling N; Ehlers S; Hölscher C
Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
[TBL] [Abstract][Full Text] [Related]
8. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
9. IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis.
Wu B; Huang C; Kato-Maeda M; Hopewell PC; Daley CL; Krensky AM; Clayberger C
Clin Immunol; 2008 Feb; 126(2):202-10. PubMed ID: 18032114
[TBL] [Abstract][Full Text] [Related]
10. Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-gamma production.
Vesosky B; Flaherty DK; Rottinghaus EK; Beamer GL; Turner J
Exp Gerontol; 2006 Nov; 41(11):1185-94. PubMed ID: 17029663
[TBL] [Abstract][Full Text] [Related]
11. Promotion of a down-modulated lung immune state may be a strategy by M. tuberculosis to foster active disease and persistence.
Ho JL; Lapa e Silva JR
Discov Med; 2010 Jan; 9(44):34-41. PubMed ID: 20102683
[TBL] [Abstract][Full Text] [Related]
12. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A
J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150
[TBL] [Abstract][Full Text] [Related]
13. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
Ordway D; Higgins DM; Sanchez-Campillo J; Spencer JS; Henao-Tamayo M; Harton M; Orme IM; Gonzalez Juarrero M
J Leukoc Biol; 2007 Nov; 82(5):1221-9. PubMed ID: 17699612
[TBL] [Abstract][Full Text] [Related]
14. The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomes.
Yoshida A; Inagawa H; Kohchi C; Nishizawa T; Soma G
Anticancer Res; 2009 Mar; 29(3):907-10. PubMed ID: 19414326
[TBL] [Abstract][Full Text] [Related]
15. Novel drug target strategies against Mycobacterium tuberculosis.
Murphy DJ; Brown JR
Curr Opin Microbiol; 2008 Oct; 11(5):422-7. PubMed ID: 18801459
[TBL] [Abstract][Full Text] [Related]
16. Human macrophage host defense against Mycobacterium tuberculosis.
Liu PT; Modlin RL
Curr Opin Immunol; 2008 Aug; 20(4):371-6. PubMed ID: 18602003
[TBL] [Abstract][Full Text] [Related]
17. Interaction of pathogenic mycobacteria with the host immune system.
Houben EN; Nguyen L; Pieters J
Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
[TBL] [Abstract][Full Text] [Related]
18. A pressure model of immune response to mycobacterium tuberculosis infection in several space dimensions.
Clarelli F; Natalini R
Math Biosci Eng; 2010 Apr; 7(2):277-300. PubMed ID: 20462290
[TBL] [Abstract][Full Text] [Related]
19. Rational design of vaccines against tuberculosis directed by basic immunology.
Reece ST; Kaufmann SH
Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
Hovav AH; Bercovier H
Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
